Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside

Publisher： Bentham Science Publishers

E-ISSN： 1875-6387 |3|2|159-167

ISSN： 1573-398x

Source： Current Respiratory Medicine Reviews, Vol.3, Iss.2, 2007-05, pp. : 159-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 69-77

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR Mutation Testing in Non-Small Cell Lung Cancer

By  

Current Respiratory Medicine Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 310-321

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview: Current Systemic Therapies for Advanced Non-Small Cell Lung Cancer

By  

Current Respiratory Medicine Reviews, Vol. 7, Iss. 5, 2011-10 ,pp. : 354-363

Bentham Science Publishers

Access to resources Recommend Favorite

Bedside Lung Ultrasound in the Care of the Critically Ill

By  

Current Respiratory Medicine Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 271-278

Bentham Science Publishers

Access to resources Recommend Favorite

Lung Cancer of Occupational Origin

By  

Current Respiratory Medicine Reviews, Vol. 8, Iss. 6, 2013-01 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite